BridgeMD
New treatment option for Sevoflurane
Official title Sevoflurane Sedation as an Alternative for Awake Fiberoptic Intubation in Difficult Airway Patients
ClinicalTrials.gov ID: NCT06601036
What this study is testing
What is Sevoflurane?
Sevoflurane is an investigational medicine, being studied as a potential treatment for sevoflurane.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The aim of this study is to compare patient satisfaction and intubating conditions with fiber optic intubation under sevoflurane sedation versus airway blocks in difficult airway patients
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50
You may be able to join if
- Age from 18 to 50 years.
- Both sexes.
- American Society of Anesthesiology (ASA) physical status I-II.
- Patients with difficult airway (Mallampati grade 3 and 4 with mouth opening less than 5 cm).
You likely can't join if
- Patient refusal.
- Patients with bleeding disorders and nasal mass.
- Allergy or intolerance to one of the study medications.
- Patients with uncontrolled systemic diseases.
- patients with gastro-esophageal reflex.
- history of nasopharyngeal surgery or drug abuse.
The study team makes the final eligibility decision.
Where it's taking place
- Tanta, El-Gharbia, Egypt
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Tanta, El-Gharbia, Egypt. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.